Integer Q1 sales up 22% to $379M; GAAP EPS $0.39, adjusted $0.87

Integer Holdings Corp

2023-Q1 EPS reported $0.39 revenue$378,785,000

Sales $379M (+22% YoY, organic +21%); GAAP net income $13M (+15%).
Non-GAAP adjusted net income $29M (+11%); adjusted diluted EPS $0.87 vs $0.78.
Adjusted EBITDA $66M (+22%); leverage ratio 3.6x; total debt $1,002M.
2023 outlook: sales $1.47B-$1.50B (7-9% growth), adjusted EPS $4.00-$4.30.
Product lines all grew: Cardio/Vascular +20%, Cardiac/Neuro +18%, Advanced Surgical/Ortho/Portable +42%, Electrochem +63%.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Integer Holdings Corp reported the three months ended March 31, 2023 results: revenue $379 million, net income $13 million, EPS $0.39 per share. Guidance reaffirmed.

Period: the three months ended March 31, 2023
Revenue: $379 million
Net income: $13 million
EPS: $0.39 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

today announced results for the three months ended March 31, 2023. First Quarter 2023 Highlights (compared to First Quarter 2022, except as noted) Sales increased 22% to $379 million, with organic growth of 21%. GAAP net income increased $2 million to $13 million, an increase of 15%. Non-GAAP adjusted net income increased $3 million to $29 million, an

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Integer Holdings Corp filing history →

Source: SEC EDGAR

accession 0001171843-23-002611

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.